AGAlbina А. Gazdanova

Albina А. Gazdanova

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Albina А. Gazdanova has a total of 80 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Study of the Effect of Palmitic Acid on the Expression of Myostatin mRNA and its Cytotoxic Properties in the Culture of Myoblast Cells and the Possibility of Exogenous Regulation

    by Vladimir G. Kukes, Vladimir A. Furalyov, Albina А. Gazdanova, Olga K. Parfenova, Dmitry V. Grishin, Nikita G. Sidorov

    Objective: To study the cytotoxic effect of palmitic acid on myoblasts in vitro and the influence of this toxicant on the expression of myostatin mRNA in myoblast culture. Methods: To research the protective action against these processes of a compound with antioxidant activity, for which 2-ethyl-6-methyl-3-hydroxypyridine malate (ethoxidol) was chosen. Results: Our studies have shown that palmitic acid has a noticeable cytostatic effect on myoblasts in vitro, significantly suppressing their proliferation: the rate of MTT recovery in myoblasts treated with palmitate was only 9.6% of that rate in control myoblasts. In experiments, it was shown that palmitic acid slightly activated the expression of myostatin mRNA. At the same time, the protective effect of 2-ethyl-6-methyl-3-hydroxypyridine malate was not so pronounced. Conclusion: The results of our research indicate that the activation of myostatin synthesis is not one of the main causes of the development of myodystrophy in obese people or people following a high-lipid diet, while the direct cytotoxic effect of palmitic acid on myoblasts is. It is obvious that the use of antioxidants such as ethoxide has a protective effect on myoblasts in the experiment and may have a certain potential in clinical practice.

  • Skin alterations as possible clinical markers of diabetes mellitus and metabolic syndrome

    by A.A. Gazdanova, N.I. Lenkova, O.V. Ryazantseva, Z.T. Astakhova, A.S. Sivkov, A.V. Perkov, S.A. Knyazeva, S.A. Solovieva, A.S. Plieva

    The review presents data on skin changes (acanthosis nigricans, xeroderma, scleredema, diabetic rubeosis, diabetic dermopathy, necrobiosis lipoidica, etc.) occurring in diabetes mellitus and other components of the metabolic syndrome. Some common potential mechanisms of development of metabolic syndrome and skin diseases such as psoriasis, acne vulgaris, hidradenitis suppurativa, androgenetic alopecia, acanthosis nigricans and atopic dermatitis are discussed. Skin manifestations may be signs of insulin resistance and impairment glucose tolerance, xanthomas and xanthelasmas are sings of dyslipidemia. Psoriasis and hidradenitis suppurativa are often associated with metabolic syndrome and obesity. Acne, hirsutism and androgenetic alopecia are widely signs of hyperandrogenism. A better understanding of correlation between metabolic syndrome and skin diseases contributes to early diagnosis and prevention, as well as provides the key to develop new therapeutic strategies. Primary care physicians, as well as dermatovenerologists and cosmetologists can play a key role in early detection and therefore earlier treatment of metabolic syndrome, contributing to the reduction of the associated with this pathological syndrome cardiovascular risk.

  • Clinical and diagnostic significance of somatic diseases skin manifestations

    by A.A. Gazdanova, S.A. Knyazeva, A.S. Ermolaeva, E.D. Drejcer, V.A. Volodina, H.A. Bunina, A.P. Ivanova, E.E. Madonova, M.A. Stepanova

    The review describes skin changes in diseases of the cardiovascular and respiratory systems, liver, pancreas, endocrine system, kidneys, inflammatory diseases of the intestine, and hematological and rheumatic diseases. Some skin manifestations, such as annular erythema and rheumatic nodules in rheumatism, Lukin and Janeway spots, Osler nodules in infective endocarditis, are among the large (in rheumatism) and small (in infective endocarditis) criteria for establishing a diagnosis. Cutaneous vasculitis is an extra-articular manifestation of Sjogren’s disease, systemic lupus erythematosus, nodular polyarteritis, and other diffuse connective tissue diseases. Erythema nodosum is seen in sarcoidosis, tuberculosis, and many autoimmune disorders. Xanthomas and xanthelasmas may indicate a lipid metabolism disorder in atherosclerosis, metabolic syndrome, and biliary cirrhosis. Patients with various skin discoloration, hyperpigmentation, and depigmentation are not uncommon in clinical practice. The correct interpretation of the skin manifestations by the first contact physician will help to make the diagnostic route of the patient shorter and more adequate and ensure not symptomatic but etiopathogenetic treatment.


  • SKIN Disorders in the pathology of the digestive organs and malabsorption syndrome in general medical practice

    by Gazdanova A.A. Gazdanova, Lenkova N.I. Lenkova, Ryazantseva O.V. Ryazantseva, Solovieva S.A. Solovieva, I.M. Sechenov First Moscow State Medical University of the Ministry of Healthcare of Russia (Sechenov University

  • Open Access

    Study of the Protective Properties of 2-Ethyl-6-Methyl-3-Hydroxypyridine Malate in the Model of In vitro-Induced Oxidative Stress in Myoblast Cell Culture

    by Vladimir A. Furalyov, Vladimir G. Kukes, Albina А. Gazdanova, Olga K. Parfenova, Nikita G. Sidorov, Roman V. Kurkin

    Background: A cellular model of oxidative stress induced by hydrogen peroxide in the primary culture of myoblasts was obtained by in vitro experiments, and the possibility of exogenous regulation of the cytotoxic effect using 2-ethyl-6-methyl-3-hydroxypyridine malate (ethoxidol) was studied. Moreover, the influence of oxidative stress and the effect of ethoxidol on the intracellular expression of such an important biomarker as myostatin was investigated. Methods: Hydrogen peroxide was used to induce oxidative stress. The effect of hydrogen peroxide on the rate of myoblast proliferation was studied by measuring the reduction level of (3-(4,5- dimethylthiazole-2-yl))-2,5-diphenyltetrazolium bromide. To measure the expression of myostatin, a real-time polymerase chain reaction (PCR-RV) method was used. Results: During the work, it was clearly demonstrated that hydrogen peroxide has a significant cytostatic effect on myoblasts in vitro, inhibiting their proliferation. Ethoxidol in physiological concentration did not show toxic effects and did not inhibit cell proliferation. This antioxidant revealed a statistically significant protective effect on the cytostatic effect of hydrogen peroxide on myoblasts. In addition, this compound inhibited the expression of myostatin mRNA caused by exposure to hydrogen peroxide as a negative regulator of growth and differentiation of muscle tissue that occurs in response to exposure to reactive oxygen species. Conclusion: Hydrogen peroxide is one of the highly active forms of oxygen and has a significant cytostatic effect on myoblasts in vitro, suppressing their proliferation. 2-ethyl-6-methyl-3- hydroxypyridine malate neutralizes the toxic effect of peroxide, thereby indirectly having a positive effect on the rate of myoblast proliferation in vitro.


  • Examination of the oral cavity as an important diagnostic tool of a primary care physician

    by Gazdanova A.A. Gazdanova, Plieva A.S. Plieva, Solovieva S.A. Solovieva, Ponomarenko T.M. Ponomarenko, I.I. Sechenov First Moscow State Medical University of the Ministry of Health of Russia (Sechenov University, Vladikavkaz North Ossetian State Medical Academy Of The Ministry Of Healthcare Of Russia

  • The significance of examination of the skin and its appendages in the rheumatic diseases diagnosis

    by Gazdanova A.A. Gazdanova, Plieva A.S. Plieva, I.I. Sechenov First Moscow State Medical University of the Ministry of Health of Russia (Sechenov University, Vladikavkaz North Ossetian State Medical Academy Of The Ministry Of Healthcare Of Russia


  • Open Access

    Study of the effect of the "Antiseptic Dorogov's stimulator" (ASD 2B-drops) on the growth of Mycobacterium tuberculosis strain

    by Сергей Владимирович Енгашев, Владимир Григорьевич Кукес, Александр Владимирович Поддубиков, Никита Геннадьевич Сидоров, Анна Юрьевна Леонова, Ольга Константиновна Парфенова, Альбина Амырхановна Газданова, Ольга Алексеевна Дорогова

    Objective - to study the effect of three different concentrations of the drug "ASD-2B drops" on the growth of M. tuberculosis strain № 22063. Materials and methods. The effect of three different concentrations of "ASD-2B drops" on the growth of M. tuberculosis strain № 22063 with a single addition of the drug into the reaction mixture was evaluated. Cultivation was carried out in Dubos broth for growing mycobacteria at 37°C for 20 days with periodic assessment of the turbidity index using a densitometer. Results. "ASD-2B drops" at a concentration of 750 µl in 10 ml of the reaction mixture after a single addition at the zero point inhibited the growth and accumulation of biomass of M.tuberculosis strain № 22063 for 10 days compared with the control. "ASD-2B drops" in lower concentrations (37.5 µl and 75 µl) contributed to an increase in the growth and accumulation of biomass of M.tuberculosis strain № 22063 compared with the control. Conclusion. The experiment demonstrated the ability of "ASD-2B drops" with a single addition to influence the growth and accumulation of biomass of M. tuberculosis strain № 22063, depending on the concentration of the drug. The presence of an inducing effect on the M. tuberculosis strain № 22063 provides a basis for further studies of the drug "ASD-2B drops".


  • Open Access

    Ophthalmic manifestations of endocrine diseases

    by A.A. Gazdanova, S.A. Knyazeva, A.A. Marakhovskaya, Yu.V. Protopopova, A.A. Sedova, J.B. Rakhimov, A.F. Salmanov, S.A. Magomedova


  • Inspection of the skin and its additives: relevance in the diagnostics of endocrine diseases

    by Gazdanova A.A. Gazdanova, Lenkova N.I. Lenkova, Ryazantseva O.V. Ryazantseva O, Solovieva S.A. Solovieva, Sivkov A.S. Sivkov, Knyazeva S.A. Knyazeva, Plieva A.S. Plieva A, I.I. Sechenov First Moscow State Medical University of the Ministry of Health of Russia (Sechenov University, Vladikavkaz North Ossetian State Medical Academy Of The Ministry Of Healthcare Of Russia